Effective July 21, 2026, Pitney Bowes Inc. has appointed finance and operations expert La Vonda Williams to its Board of Directors. Williams, who brings nearly 20 years of leadership experience, will contribute to the Audit, Governance, and Strategic Review Committees as the company advances its previously announced strategic review process.
Key Points
- NYSE: PBI-PB
- La Vonda Williams joins Pitney Bowes Board of Directors as of July 21, 2026
- Williams appointed to Audit, Governance, and Strategic Review Committees; compensated with $200,000 base retainer plus committee fees and equity grants
- Appointment publicly disclosed on July 27, 2026 amid ongoing strategic review initiative
Leadership and Professional Experience of La Vonda Williams
La Vonda Williams brings a robust background in finance and operations to Pitney Bowes' Board. With nearly two decades of leadership roles spanning startups and leading investment banks, her expertise covers diverse industries and organizational scales.
Williams served as Chief Financial Officer at Onegevity Health, a precision health intelligence firm, from 2019 until its acquisition by Thorne HealthTech, Inc. in 2021. Prior to that, she was Vice President of Equity Derivatives Operations at Goldman Sachs between 2014 and 2019, gaining deep knowledge of complex financial instruments. Earlier, she held the Chief Operating Officer role at Solaire Generation, Inc., a solar energy equipment company, showcasing her operational leadership in renewable energy.
Board Committee Roles and Governance Duties
Williams will serve on Pitney Bowes’ Audit Committee, Governance Committee, and the newly formed Strategic Review Committee. Her financial acumen aligns with her Audit Committee role, while her governance experience supports her participation in the Governance Committee, which oversees board composition and corporate policies. The Strategic Review Committee, created specifically for the company’s ongoing strategic evaluation, benefits from her analytical expertise.
Her appointment to the Strategic Review Committee highlights Pitney Bowes’ focus on thorough oversight during its strategic review. Williams previously served as an Independent Director and Audit Committee member at Altra Industrial Motion Corporation (NASDAQ:AIMC) from 2021 to 2023, reinforcing her board-level financial oversight credentials.
Director Compensation Details
Under Pitney Bowes’ standard non-management director compensation program, Williams will receive an annual cash retainer of $200,000. Additional cash retainers include $20,000 for Audit Committee service and $12,000 for Governance Committee participation.
Equity compensation consists of restricted stock units valued at $100,000 annually, prorated to $81,095 for her mid-2026 start, vesting one year after grant. For her Strategic Review Committee role, she will receive an extra equity grant worth $278,000 annually, prorated to $225,446 for 2026, also vesting after one year.
Academic and Professional Credentials
Williams holds an M.B.A. from Stanford University and a B.S. in Mechanical Engineering from Harvard University. This blend of engineering and advanced business education equips her to assess both operational and financial facets of industrial and technology companies.
Her career progression across investment banking, health technology, renewable energy, and industrial manufacturing sectors demonstrates versatility and a comprehensive understanding of diverse business environments.
Strategic Review Committee and Corporate Evaluation Context
The Strategic Review Committee was established in connection with Pitney Bowes’ announced strategic alternatives evaluation. While specific details about the review’s scope and timeline remain undisclosed, the committee ensures formal board governance over this critical process.
Williams’ immediate inclusion in this committee underscores management’s reliance on her financial and operational insight during the strategic review. The additional equity compensation tied to this committee reflects the company’s emphasis on strong independent director engagement in the initiative.
Announcement and Disclosure Timeline
Williams’ board appointment took effect on July 21, 2026, with a public announcement following on July 27, 2026. The press release, filed as Exhibit 99.1 under Item 7.01, aligns with standard disclosure practices, providing transparency to shareholders and market participants.
The filing clarifies that the Item 7.01 disclosure and press release are not "filed" under Section 18 of the Securities Exchange Act, reflecting their classification as announcements rather than formal financial or material event filings.
No Related Party Transactions or Conflicts of Interest
The filing confirms no arrangements or understandings exist between Williams and any other parties regarding her board appointment, ensuring the selection was made independently. Additionally, Williams is not involved in any transactions requiring disclosure under Item 404(a) of Regulation S-K, affirming the absence of material related-party dealings prior to her appointment.
Deferred Compensation and Expense Reimbursement
Williams is eligible to participate in the Directors' Deferred Incentive Savings Plan, allowing deferral of compensation for tax planning purposes. Details of this plan are outlined in the company’s proxy statement.
She will also be reimbursed for reasonable out-of-pocket expenses related to Board and Committee meetings, consistent with standard corporate governance policies detailed in the proxy statement.
Impact on Board Expertise and Oversight
Williams’ appointment strengthens Pitney Bowes’ Board with her financial expertise and operational leadership, vital during the strategic review phase. Her background in equity derivatives at Goldman Sachs equips her to navigate complex financial considerations, while her CFO and COO experience supports insights into operational transformation.
Her diverse industry experience in health technology, renewable energy, and industrial manufacturing broadens the Board’s perspective on evolving business models. Prior audit committee service enhances her capability to oversee financial reporting and internal controls, critical for evaluating strategic alternatives and associated risks.